申请人:Link John O.
公开号:US20080293819A1
公开(公告)日:2008-11-27
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
本发明涉及一种抑制半胱氨酸蛋白酶的化合物,特别是抑制蛋白酶B、K、L、F和S,因此对于治疗由这些蛋白酶介导的疾病是有用的。本发明涉及含有这些化合物的制药组合物以及制备它们的方法。